You are here

Chronic Hepatitis C

FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C

Marketwatch

Fri, 04/24/15 - 10:55 am

Chronic Hepatitis C

IDX719 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection

Yahoo

Wed, 07/25/12 - 09:37 am

Chronic Hepatitis C

Merck and Roche Expand Agreement in Fight Against Chronic Hepatitis C

Yahoo

Wed, 07/20/11 - 10:22 am

Chronic Hepatitis C

Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

CNN Money

Sat, 04/25/09 - 10:54 am

Chronic Hepatitis C